Prakt. lékáren. 2014; 10(4): 142-145

Prevention of diseases of the urinary tract

Miroslava Romžová
Urologická klinika Fakultní nemocnice Hradec Králové

The author points to the different possibilities of self-healing techniques diseases of the urinary tract. Those of a range, of from infection,

through stones, urinary incontinence, benign prostatic hyperplasia, to cancer. Most urological diseases can be prevented by proper

prevention. This is the basis of self-medication of patients.

urinary tract.

Keywords: self-medication, prevention of infection, urinary incontinence, stone disease, benign prostatic hyperplasia, cancer of the

Published: August 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Romžová M. Prevention of diseases of the urinary tract. Praktické lékárenství. 2014;10(4):142-145.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002; 168(4 Pt 2): 1720-1722. Go to original source... Go to PubMed...
    2. Rüden H, Gastmeier P, Daschner FD, et al. Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP). Infection 1997; 25(4): 199-202. Go to original source... Go to PubMed...
    3. Naber KG, Schito G, Botto H, et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54(5): 1164-1175. Go to original source... Go to PubMed...
    4. Jepson RG1, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012 Oct 17; 10: CD001321. doi: 10.1002/14651858.CD001321.pub5.
    5. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infections. Clin Infect Dis 2011; 52(10): 1212-1217. Go to original source... Go to PubMed...
    6. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic". Microbes Infect 1999; 2(2): 125-129. doi: 10.1016/S1286-4579(99)80003-3. Go to original source... Go to PubMed...
    7. Leusmann DB. Results of 5035 stone analyses: A contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol 1990; 24: 205-210. Go to original source... Go to PubMed...
    8. Hesse A, Brandle E, Wilbert D, et al. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 2003; 44(6): 709-713.
    9. Strohmaier WL. Course of calcium stone disease without treatment. What can we expect? Eur Urol 2000; 37(3): 339-344. Go to original source... Go to PubMed...
    10. Keoghane S, Walmsley B, Hodgson D. The natural history of untreated renal tract calculi. BJU Int 2010; 105(12): 1627-1629. Go to original source... Go to PubMed...
    11. Straub M, Strohmaier WL, Berg W, et al. Diagnosis and metaphylaxis of stone disease Consensus concept of the National Working Committee on Stone Disease for the Upcoming German Urolithiasis Guideline. World J Urol 2005; 23(5): 309-323. Go to original source... Go to PubMed...
    12. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996; 155(3): 839-843. Go to original source... Go to PubMed...
    13. Fink HA, Akornor JW, Garimella PS, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 2009; 56(1): 72-80. Go to original source... Go to PubMed...
    14. Hesse AT, Tiselius H-G. Siener R, Hoppe B. (Eds). Urinary Stones, Diagnosis, Treatment and Prevention of Recurrence. 3rd edn. Basel, S. Karger AG, 2009. ISBN 978-3-8055-9149-2. Go to original source...
    15. Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol 1998; 9(9): 1645-1652. Go to original source... Go to PubMed...
    16. Siener R, Glatz S, Nicolay C, et al. The role of overweight and obesity in calcium oxalate stone formation. Obes Res 2004; 12(1): 106-113. Go to original source... Go to PubMed...
    17. Haylen BT, Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Rizk DE, Sand PK, Schaer GN. An international urogynecological association (IUGA)/international kontinence society (ICS) join report on the terminology for fiale pelvic floor dysfuntion. Int Urogynecol J, 2010; 21: 5-26. Go to original source... Go to PubMed...
    18. Lucas MG, Bedretdinova D, Bosch JLRH, Burkhard F, Cruz F, Nambiar AK, Nilsson CG, de Ridder DJMK, Tubaro A, Pickard RS. Guidelines on Urinary Incontinence, European Association of Urology 2014.
    19. Swithinbank L, Hashim H, Abrams P. The effect of fluid intake on urinary symptoms in women. J Urol 2005; 174(1): 187-189. Go to original source... Go to PubMed...
    20. Zimmern P, Litman HJ, Mueller E, et al. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int 2010; 105(12): 1680-1685. Go to original source... Go to PubMed...
    21. Coyne KS, Cash B, Kopp Z, et al. The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int 2011; 107(2): 254-261. Go to original source... Go to PubMed...
    22. Danforth KN, Townsend MK, Lifford K, et al. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006; 194(2): 339-345. Go to original source... Go to PubMed...
    23. Hannestad YS, Rortveit G, Daltveit AK, et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 2003; 110(3): 247-254. Go to original source...
    24. Nygaard I, DeLancey JO, Arnsdorf L, et al. Exercise and incontinence. Obstet Gynecol Nygaard 1990; 75(5): 848-851. Go to original source... Go to PubMed...
    25. Kikuchi A, Niu K, Ikeda Y, et al. Association between physical activity and urinary incontinence in a community-based elderly population aged 70 years and over. Eur Urol 2007; 52(3): 868-874. Go to original source... Go to PubMed...
    26. Kegel AH. Progressive resistance exercise in the functional restoration of the perineal muscles. Am J Ostet Gyn, 1948; 56: 238. Go to original source... Go to PubMed...
    27. Romžová M, Hurtová M, Pacovský J, Broďák M. Inkontinence moči ve stáří. Urolog. pro Praxi, 2010; 11(3): 119-123.
    28. Bo K. Pelvic floor muscles exercise for the treatment of stress incontinence: an exercise physiology perspective. Int Urogynecol J, 1995; 6: 282. Go to original source...
    29. Berghmans B1, van Waalwijk van Doorn E, Nieman F, et al. Efficacy of physical therapeutic modalities in women with proven bladder overactivity. Eur Urol 2002; 41(6): 581-587. Go to PubMed...
    30. Urinary incontinence: the management of urinary incontinence in women. Clinical guidelines CG171. National Institute for Health and Clinical Excellence, September 2013.
    31. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132(3): 474-479. Go to original source... Go to PubMed...
    32. Brown CT, Yap T, Cromwell DA, et al. Self-management for men with lower urinary tract symptoms - a randomised controlled trial. BMJ 2007; 334(7583): 25. Go to original source... Go to PubMed...
    33. Yap TL, Brown C, Cromwell DA, et al. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures. BJU Int 2009; 104(8): 1104-1108. Go to original source... Go to PubMed...
    34. Brown CT, van der Meulen J, Mundy AR, et al. Defining the components of self-management programme in men with lower urinary tract symptoms: a consensus approach. Eur Urol 2004; 46(2): 254-263. Go to original source... Go to PubMed...
    35. Madersbacher S, Berger I, Ponholzer A, et al. Plant extracts: sense or nonsense? Current Opin Urol 2008; 18(1): 16-20. Go to original source... Go to PubMed...
    36. Wilt T, Ishani A, Mac Donald R, et al. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database of Syst Rev 2000; (2): CD001043. Go to original source...
    37. Stárka L, Sosvorová L, Mikšátková P. Herbální přípravky používané při léčbě příznaků benigní hyperplazie prostaty. Urol. praxi, 2012; 13(6): 239-244.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.